Skip to content
Peptigraph home

BPC-157 Dosage: Doses Studied, Units and Chart

What doses of BPC-157 have been used in published research, how they convert to syringe units, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGastric pentadecapeptideUpdated
Doses studied
15 studies
with a stated dose, listed below
Frequency
Varies by study
as used in studies
Half-life
less than 30 min
IV and IM (single and repeated), rat, beagle dog · Frontiers in pharmacology 2022, PMID 36588717
Vial sizes sold
2 mg, 5 mg, 10 mg, 20 mg

Doses used in published studies

Each dose below is quoted from a study abstract, strongest design first. Animal doses are labelled and do not translate directly to people. None of them is a recommendation.

Doses of BPC-157 used in published studies
DoseFrequency and routeStudy typeSource
10 mg (day 1) and 20 mg (day 2) in 250 cc normal salineonce daily on 2 consecutive days · intravenous infusion over one hour · 2 daysHuman uncontrolled trialn = 2Alternative therapies in health and medicine 2025, PMID 40131143
10 mg totalsingle procedure · injection around the inflamed bladder area during cystoscopyHuman uncontrolled trialn = 12Alternative therapies in health and medicine 2024, PMID 39325560
BPC-157 10 ug/kg/day; TB-500 60 ug/kg/daydaily · intraperitoneal · four weeksAnimal · rat (not a human result)n = 32Joint diseases and related surgery 2026, PMID 42542926
10, 20 or 40 ug/kgNot stated in the abstractAnimal · rat (not a human result)Journal of dental anesthesia and pain medicine 2022, PMID 35449779
10 ng/kg, 10 ug/kgintraperitonealAnimal · rat (not a human result)Biomedicines 2022, PMID 35203478
0.4 ug/eye, 0.4 ng/eye; 10 ug/kg, 10 ng/kgeye drops, intraperitoneal or drinking water · six weeksAnimal · rat (not a human result)Biomedicines 2021, PMID 35052769
200 or 2 ug/kgsingle injection 10 min after injury · intraperitonealAnimal · rat (not a human result)Journal of orthopaedic surgery and research 2019, PMID 31266512
10 ug/kgbath applied to the colon segmentAnimal · rat (not a human result)World journal of gastroenterology 2017, PMID 29358856
10 ug/kg or 10 ng/kgonce daily · intraperitoneal or in drinking waterAnimal · rat (not a human result)Journal of physiology and pharmacology 2013, PMID 24304574
10 microg or 10 ng/kg i.p.; 1.0 microg/g cream topically; 0.16 microg/ml in drinking wateronce daily · intraperitoneal, topical cream or oral (drinking water)Animal · rat (not a human result)Journal of orthopaedic research 2010, PMID 20225319
10 microg, 10 ng/kgintraperitoneal, intragastric or localAnimal · rat (not a human result)Regulatory peptides 2010, PMID 19903499
10 microg/kg, 10 ng/kgcontinuously in drinking water, or once daily i.p. · drinking water or intraperitonealAnimal · rat (not a human result)Journal of pharmacological sciences 2008, PMID 18818478
1 microg, 1 ng or 1 pg per g of neutral creamonce daily · topical creamAnimal · mouse (not a human result)Burns 2005, PMID 15774286
10 microg, 10 ng or 10 pg/kgonce daily, first dose 30 min after surgery · intraperitonealAnimal · rat (not a human result)Journal of orthopaedic research 2003, PMID 14554208
10 microg or 10 ng/kgonce daily (postoperative days 7-21) or intermittent doses on postoperative days 7, 9, 14 and 16 · local percutaneous or intramuscular · postoperative days 7-21 for the daily regimenAnimal · rabbit (not a human result)Bone 1999, PMID 10071911

Dose to syringe units

For a 10 mg vial mixed with 2 mL of bacteriostatic water (5 mg/mL), on a U-100 syringe. These are reference amounts for the math, not suggested doses.

100 mcg
2 u
200 mcg
4 u
250 mcg
5 u
300 mcg
6 u
400 mcg
8 u
500 mcg
10 u
Use your own vial and water

Before anyone considers it

  • BPC-157 is not FDA approved for any use.
  • Products sold as research chemicals are not checked by the FDA for identity, purity or dose.
  • Reconstitution math (mg vs mcg, units vs mL) is the most asked question in peptide forums. Check every number twice.
  • People who are pregnant, breastfeeding, or have a chronic condition need medical advice first.

What amounts the three human reports used

The only human report with different amounts on different days is an intravenous pilot: 10 mg on day 1 and 20 mg on day 2, each in 250 cc of saline over one hour.[5]

The interstitial cystitis pilot reports one total amount, delivered by injection around the bladder inflammation during a single cystoscopy.[6]

The knee-pain report is a retrospective chart review, and its abstract states no dose, volume or schedule.[21]

Drugs@FDA lists no BPC-157 product, so no FDA label gives a dose or escalation schedule.[22]

What the animal studies dosed, per kilogram of body weight

In rats with a transected medial collateral ligament, BPC 157 was reported effective when given once daily intraperitoneally (10 microg or 10 ng/kg) or applied as a thin layer of cream (1.0 microg per g of cream) at the injury site.[14]

In a rat Achilles tendon study, BPC-157 was given at 10 µg/kg/day and TB-500 at 60 µg/kg/day, both intraperitoneally.[7]

In that rat tendon study the combination of the two peptides did not give additional benefit over either alone.[7]

Why a schedule cannot be derived

The IV pilot reported that up to 20 mg in 2 healthy adults showed no adverse effects and was well tolerated.[5]

Common questions

How many units is 250 mcg of BPC-157?

It depends on the water added. A 10 mg vial with 2 mL of water gives 5 mg/mL, so 250 mcg is 5 units on a U-100 syringe. Use the calculator for other mixes.

Is BPC-157 FDA approved?

No. BPC-157 is not FDA approved for any use. The FDA removed it from Category 2 on 15 Apr 2026. Its advisory committee voted 8–6 in July 2026 to add it to the 503A compounding list. That vote is not final.

What dose of BPC-157 was used in human studies?

The bladder pilot used a total of 10 mg around the inflamed area in one procedure.[6]

Is there a standard BPC-157 protocol or cycle?

The Drugs@FDA search found no BPC-157 product, so no FDA label sets a dose, interval or cycle length.[22]

More on BPC-157

Sources

  1. 1Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2; 'nominated but withdrawn' table, content current as of 22 Apr 2026)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  2. 2Pharmacy Compounding Advisory Committee meeting, 23–24 Jul 2026 (agenda and materials)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  3. 3Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  4. 4BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  5. 5Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.Alternative therapies in health and medicine · 2025PMID 40131143Accessed 2 Oct 2026
  6. 6Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study.Alternative therapies in health and medicine · 2024PMID 39325560Accessed 2 Oct 2026
  7. 7Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.Joint diseases and related surgery · 2026PMID 42542926Accessed 2 Oct 2026
  8. 8The anti-nociceptive effect of BPC-157 on the incisional pain model in rats.Journal of dental anesthesia and pain medicine · 2022PMID 35449779Accessed 2 Oct 2026
  9. 9Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats.Biomedicines · 2022PMID 35203478Accessed 2 Oct 2026
  10. 10Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma.Biomedicines · 2021PMID 35052769Accessed 2 Oct 2026
  11. 11Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats.Journal of orthopaedic surgery and research · 2019PMID 31266512Accessed 2 Oct 2026
  12. 12Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights.World journal of gastroenterology · 2017PMID 29358856Accessed 2 Oct 2026
  13. 13Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2013PMID 24304574Accessed 2 Oct 2026
  14. 14Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2010PMID 20225319Accessed 2 Oct 2026
  15. 15Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury.Regulatory peptides · 2010PMID 19903499Accessed 2 Oct 2026
  16. 16Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.Journal of pharmacological sciences · 2008PMID 18818478Accessed 2 Oct 2026
  17. 17The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice.Burns : journal of the International Society for Burn Injuries · 2005PMID 15774286Accessed 2 Oct 2026
  18. 18Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2003PMID 14554208Accessed 2 Oct 2026
  19. 19Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation.Bone · 1999PMID 10071911Accessed 2 Oct 2026
  20. 20Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.Frontiers in pharmacology · 2022PMID 36588717Accessed 2 Oct 2026
  21. 21Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.Alternative therapies in health and medicine · 2021PMID 34324435Accessed 2 Oct 2026
  22. 22Drugs@FDA (openFDA) search: active ingredient "BPC-157"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026

Found an error? Report a correction.